Transcell Biologics

Transcell Biologics is an innovation-driven biotech company specializing in stem cell-based therapies and predictive platforms. Its main offerings include clinical-grade progenitor cells, adult stem cell-based predictive platforms, small molecules for neurogenesis/neuroprotection, and a proprietary digital animal replacement testing system. The company's pipeline includes pre-clinical candidates targeting cancers, neurodegenerative disorders, muscular dystrophies, and periodontal disease. It also operates a commercial biosamples repository supporting personalized medicine through genomics-stem cell integration. No late-stage clinical results are reported as of June 2025.